Balloon angioplasty in acute myocardial infarction - Limitations of thrombolytic therapy when used alone

R. S. Stack, R. M. Califf, H. R. Phillips, D. B. Pryor, P. J. Quigley, R. P. Bauman, J. E. Tcheng, J. C. Greenfield

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Clinical perspective: Although thrombolytic therapy offers important, often life-preserving benefits to many AMI patients, its effectiveness is limited in several crucial respects: it does not achieve reperfusion in a substantial percentage of patients, nor does it reduce the underlying coronary lesion. In addition, its effectiveness cannot be predicted or reliably assessed by currently available noninvasive means in many AMI patients.

Original languageEnglish
JournalAmerican Journal of Cardiology
Volume62
Issue number10 PART II
StatePublished - Jan 1 1988
Externally publishedYes

Fingerprint

Balloon Angioplasty
Thrombolytic Therapy
Myocardial Infarction
Reperfusion

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Stack, R. S., Califf, R. M., Phillips, H. R., Pryor, D. B., Quigley, P. J., Bauman, R. P., ... Greenfield, J. C. (1988). Balloon angioplasty in acute myocardial infarction - Limitations of thrombolytic therapy when used alone. American Journal of Cardiology, 62(10 PART II).

Balloon angioplasty in acute myocardial infarction - Limitations of thrombolytic therapy when used alone. / Stack, R. S.; Califf, R. M.; Phillips, H. R.; Pryor, D. B.; Quigley, P. J.; Bauman, R. P.; Tcheng, J. E.; Greenfield, J. C.

In: American Journal of Cardiology, Vol. 62, No. 10 PART II, 01.01.1988.

Research output: Contribution to journalArticle

Stack, RS, Califf, RM, Phillips, HR, Pryor, DB, Quigley, PJ, Bauman, RP, Tcheng, JE & Greenfield, JC 1988, 'Balloon angioplasty in acute myocardial infarction - Limitations of thrombolytic therapy when used alone', American Journal of Cardiology, vol. 62, no. 10 PART II.
Stack RS, Califf RM, Phillips HR, Pryor DB, Quigley PJ, Bauman RP et al. Balloon angioplasty in acute myocardial infarction - Limitations of thrombolytic therapy when used alone. American Journal of Cardiology. 1988 Jan 1;62(10 PART II).
Stack, R. S. ; Califf, R. M. ; Phillips, H. R. ; Pryor, D. B. ; Quigley, P. J. ; Bauman, R. P. ; Tcheng, J. E. ; Greenfield, J. C. / Balloon angioplasty in acute myocardial infarction - Limitations of thrombolytic therapy when used alone. In: American Journal of Cardiology. 1988 ; Vol. 62, No. 10 PART II.
@article{f56066ab83f54faea125d09ac017045d,
title = "Balloon angioplasty in acute myocardial infarction - Limitations of thrombolytic therapy when used alone",
abstract = "Clinical perspective: Although thrombolytic therapy offers important, often life-preserving benefits to many AMI patients, its effectiveness is limited in several crucial respects: it does not achieve reperfusion in a substantial percentage of patients, nor does it reduce the underlying coronary lesion. In addition, its effectiveness cannot be predicted or reliably assessed by currently available noninvasive means in many AMI patients.",
author = "Stack, {R. S.} and Califf, {R. M.} and Phillips, {H. R.} and Pryor, {D. B.} and Quigley, {P. J.} and Bauman, {R. P.} and Tcheng, {J. E.} and Greenfield, {J. C.}",
year = "1988",
month = "1",
day = "1",
language = "English",
volume = "62",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "10 PART II",

}

TY - JOUR

T1 - Balloon angioplasty in acute myocardial infarction - Limitations of thrombolytic therapy when used alone

AU - Stack, R. S.

AU - Califf, R. M.

AU - Phillips, H. R.

AU - Pryor, D. B.

AU - Quigley, P. J.

AU - Bauman, R. P.

AU - Tcheng, J. E.

AU - Greenfield, J. C.

PY - 1988/1/1

Y1 - 1988/1/1

N2 - Clinical perspective: Although thrombolytic therapy offers important, often life-preserving benefits to many AMI patients, its effectiveness is limited in several crucial respects: it does not achieve reperfusion in a substantial percentage of patients, nor does it reduce the underlying coronary lesion. In addition, its effectiveness cannot be predicted or reliably assessed by currently available noninvasive means in many AMI patients.

AB - Clinical perspective: Although thrombolytic therapy offers important, often life-preserving benefits to many AMI patients, its effectiveness is limited in several crucial respects: it does not achieve reperfusion in a substantial percentage of patients, nor does it reduce the underlying coronary lesion. In addition, its effectiveness cannot be predicted or reliably assessed by currently available noninvasive means in many AMI patients.

UR - http://www.scopus.com/inward/record.url?scp=0023681904&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023681904&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0023681904

VL - 62

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 10 PART II

ER -